AIMMUNE THERAPEUTICS INC's ticker is AIMT and the CUSIP is 00900T107. A total of 92 filers reported holding AIMMUNE THERAPEUTICS INC in Q4 2016. The put-call ratio across all filers is 0.28 and the average weighting 1.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2020 | $8,780,000 | +15.5% | 525,423 | -0.3% | 0.38% | -13.0% |
| Q1 2020 | $7,602,000 | -62.7% | 527,150 | -13.5% | 0.44% | -49.0% |
| Q4 2019 | $20,401,000 | +59.6% | 609,523 | -0.2% | 0.86% | +44.4% |
| Q3 2019 | $12,784,000 | -26.9% | 610,511 | -27.4% | 0.60% | -15.1% |
| Q2 2019 | $17,500,000 | -8.2% | 840,531 | -1.5% | 0.70% | -9.4% |
| Q1 2019 | $19,064,000 | +7.4% | 852,991 | +15.0% | 0.78% | -11.1% |
| Q4 2018 | $17,743,000 | +33.6% | 741,746 | +52.4% | 0.87% | +78.9% |
| Q3 2018 | $13,276,000 | +9.6% | 486,666 | +8.0% | 0.49% | +6.8% |
| Q2 2018 | $12,112,000 | -17.0% | 450,436 | -1.8% | 0.46% | -21.9% |
| Q1 2018 | $14,599,000 | -17.5% | 458,640 | -2.0% | 0.58% | -14.2% |
| Q4 2017 | $17,704,000 | +31.8% | 468,113 | -13.6% | 0.68% | +24.7% |
| Q3 2017 | $13,437,000 | +16.9% | 542,035 | -3.0% | 0.55% | +14.0% |
| Q2 2017 | $11,492,000 | -9.4% | 558,946 | -4.2% | 0.48% | -7.9% |
| Q1 2017 | $12,681,000 | -19.8% | 583,566 | -24.5% | 0.52% | -22.7% |
| Q4 2016 | $15,808,000 | +127.0% | 772,995 | +66.5% | 0.67% | +117.4% |
| Q3 2016 | $6,965,000 | +138.0% | 464,364 | +71.7% | 0.31% | +119.9% |
| Q2 2016 | $2,927,000 | -20.1% | 270,510 | +0.2% | 0.14% | -20.8% |
| Q1 2016 | $3,662,000 | -26.6% | 270,060 | -0.1% | 0.18% | -24.6% |
| Q4 2015 | $4,988,000 | +378.7% | 270,358 | +557.2% | 0.24% | +337.0% |
| Q3 2015 | $1,042,000 | – | 41,140 | – | 0.05% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Foresite Capital Management II, LLC | 3,300,797 | $90,046,000 | 33.32% |
| Aisling Capital LLC | 1,990,000 | $54,287,000 | 11.73% |
| Foresite Capital Management III, LLC | 801,240 | $21,858,000 | 4.82% |
| PACIFIC VIEW ASSET MANAGEMENT, LLC | 189,857 | $5,181,000 | 4.12% |
| AlpInvest Partners B.V. | 38,943 | $1,062,000 | 2.27% |
| Eventide Asset Management | 1,739,000 | $47,440,000 | 1.74% |
| Palo Alto Investors LP | 1,381,759 | $37,694,000 | 1.52% |
| Sofinnova Investments, Inc. | 222,295 | $6,064,000 | 0.54% |
| DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 553,000 | $15,086,000 | 0.54% |
| EMERALD ADVISERS, LLC | 486,666 | $13,276,000 | 0.49% |